Overview
Diala Ezzeddine is a Co-Founder and Chief Operating Officer (COO) at Differentiated Therapeutics, a role she has held since January 2021. Differentiated Therapeutics is focused on designing and developing disease-modifying TPD therapies for patients with unmet medical needs.
Professional Experience
- Chief Operating Officer, Differentiated Therapeutics (2021 - Present): Diala co-founded Differentiated Therapeutics, bringing her extensive experience in bio-pharmaceutical leadership to the new venture.
- CEO, Airbase Breathing Company (2020 - 2021): Led the company's operations and strategic directions during her tenure.
- Principal, InPact Bio (2020): Provided high-level strategic consulting.
- CEO, Xios Therapeutics (2016 - 2020): Oversaw the company’s growth and product development initiatives.
- Executive Vice President & Chief Business Officer, X-Chem, Inc. (2015): Managed multiple facets of business development and organizational strategy.
- Chief Business Officer, X-Chem, Inc. (2010 - 2014): Guided business strategy and operations.
- Senior Business Advisor, X-Body, Inc. (2010): Offered expertise in business strategy.
- Head of Business Development, Archemix Corp (2008 - 2009): Directed business development efforts.
- Consultant, BioAssets Development Corp. (2007 - 2008): Delivered strategic consulting services.
- Co-Founder & CEO, HydroSpine, Inc. (2006 - 2007): Initiated and managed the start-up.
- Business Development Roles, Millennium Pharmaceuticals, Inc. (1999 - 2004): Gained valuable experience in various business development functions.
Education
- Ph.D. in Genetics, Harvard Medical School
- MS in Biology, Boston University
- BS in Biology/Geology, American University of Beirut, Lebanon
In addition, Diala has attended:
- Boardroom Ready Program, Women In Bio (2018): Participated in a program aimed at preparing women for boardroom roles.
- École des Roches and Collège Protestant Français de Beyrouth: Earlier educational background with no specific degrees mentioned.
Key Achievements
- Fundraising: Differentiated Therapeutics successfully raised $5 million in a seed round as of August 2022, showcasing effective financial and strategic management under Diala's leadership.
- Leadership: Diala has demonstrated strong leadership skills across various biotech companies, from start-ups to established firms, consistently performing in high-stakes roles such as CEO and COO.
Professional Network
- Greater Boston Area: Diala Ezzeddine is based in the Greater Boston area and has built a professional network with over 500 connections on LinkedIn.
Online Presence
For further details on Diala’s professional background and current role, refer to her LinkedIn profile: [LinkedIn Profile](https://www.linkedin.com/in/dialaezzeddine-biotech)
Summary
Diala Ezzeddine is a highly accomplished biotech executive with extensive experience in business development, strategic consulting, and leadership roles across several prominent organizations. Her role as Co-Founder and COO at Differentiated Therapeutics highlights her ability to drive company growth and innovate in the field of therapeutic development. Her educational background, coupled with her diverse professional experience, makes her a valuable asset in the biotechnology industry.
